Human endometrium as a neuroendocrine tissue: Expression, regulation and biological roles of endometrial corticotropin-releasing hormone (CRH) and opioid peptides

Journal of Endocrinological Investigation

Volumn 20, Issue 3, 1997, Pages 158-167

  Zoumakis, E ^a   Margioris, A N ^a   Makrigiannakis, A ^a   Stournaras, C ^a   Gravanis, A ^a,b  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

CRH; Endometrium; Implantation; Opioids

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROPEPTIDE; OPIATE PEPTIDE;

DECIDUALIZATION; ENDOMETRIUM; FEMALE; HORMONAL REGULATION; HUMAN; NEUROENDOCRINE SYSTEM; NIDATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; STROMA; UTERUS CONTRACTILITY; VASCULARIZATION;

EID: 0030966907     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346896     Document Type: Review

References (98)

1. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β-endorphin. Science 213: 1394, 1981.
2. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson A. Chemical and biological characterization of corticotropin-releasing factor. Recent Prog. Horm. Res. 39: 245, 1983.
3. Antoni F.A. Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocr. Rev. 7: 351, 1986.
4. Orth D. Corticotropin-releasing hormone in humans. Endocr. Rev. 13: 164, 1992.
5. Usui T., Nakai Y., Tsukada T., Jingami H., Takahashi H., Fucada J. Expression of adrenocorticotropin-releasing hormone precursor gene in placenta and other nonhypothalamic tissues in man. Mol. Endocrinol. 2: 871, 1988.
6. Suda T., Tomori N., Tozawa F., Mouri T., Demoura H., Shizume K. Distribution and characterization of immunoreactive corticotropin-releasing factor in human tissues. J. Clin. Endocrinol. Metab. 59: 861, 1984.
7. Petrusz P., Merghenthaler I., Maderdrut L., Vigh S., Schally A. Corticotropin-releasing factor-like immunoreactivity in the vertebrate endocrine pancreas. Proc. Natl. Acad. Sci. 80: 1721, 1983.
8. Petrusz P., Merghenthaler I., Ordronneau P., Maderdrut L., Vigh S., Schally A. Corticotropin-releasing factor-like immunoreactivity in the gastro-entero-pancreatic endocrine system. Peptides 5: 71, 1984.
9. Dammrich J., Ormanns W., Kahaly G., Schrezenmeir J. Multiple peptide hormone producing adenocarcinoma of lung with neurotensin and CRF-like immunoreactivity. Pathol. Res. Pract. 183: 670, 1988.
10. Owens M.J., Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43: 425, 1991.
11. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J.M., Vale W.W. Cloning and characterization of human urocortin. Endocrinology 137: 2167, 1996.
12. Ross P.C., Kostas C.M., Ramabhadran T.V. A variant of the human corticotropin-releasing factor (CRF) receptor: cloning, expression and pharmacology. Biochem. Biophys. Res. Comun. 205: 1836, 1994.
13. Hilllhouse E.W., Grammatopoulos D., Milton N.G., Quartero H.W. The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy. J. Clin. Endocrinol. Metab. 76: 736, 1993.
14. Smets G., Van-Gompel J., Meyer C., Abs R., de-Menten Y., Kloppel G. Corticotropin-releasing hormone receptors on human pituitary cells: autoradiography at the light microscopical level, quantification and immunocytochemistry. Prog. Histochem. Cytochem. 26: 107, 1992.
15. Polymeropoulos M.H., Torres R., Yanovski J.A., Chandrasekharappa S.C., Ledbetter D.H. The human corticotropin-releasing factor receptor (CRHR) gene maps to chromosome 17q12-q22. Genomics 28: 123, 1995.
16. Xiong Y., Xie L.Y., Abou-Samra A.B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor. Endocrinology 136: 1828, 1995.
17. Perrin M., Donaldson C., Chen R., Blount A., Berggren T., Bilezikjian L., Sawchenko P., Vale W. Identification of a second corticotropin-releasing factor receptor gene and characterization of a cDNA expressed in heart. Proc. Natl. Acad. Sci. 92: 2969, 1995.
18. Kishimoto T., Pearse R.V. 2nd, Lin C.R., Rosenfeld M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92: 1108, 1995.
19. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA 92: 836, 1995.
20. Grigoriadis D.E., Heroux J.A., De Souza E.B. Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems. Ciba Found. Symp. 172: 85, discussion 101-7, 1993.
21. Chang C.P., Pearse R.V. 2d, O' Connell S., Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11: 1187, 1993.
22. Chen R., Lewis K.A., Perrin M.H., Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc. Natl. Acad. Sci. 90: 8967, 1993.
23. Hughes J. Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res. 88: 295, 1975.
24. Hughes J., Smith T.W., Kosterlitz H.G., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258: 577, 1975.
25. Lynch D.R., Snyder S.H. Neuropeptides: Multiple molecular forms, metabolic pathways and receptors. Ann. Rev. Biochem. 55: 773, 1986.
26. Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides:multiple agonists and receptors. Nature 267: 495, 1977.
27. Numa S. Opioid peptide precursors and their genes. In: Gross E., Meienhofer J. (Eds.), The peptides. Academic Press, New York, 1984, vol. 6, p. 1.
28. Chavkin C., Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature 291: 591, 1981.
29. Shultz R., Wuster M., Herz A. Endogenous ligands for k-opiate receptors. Peptides 3: 973, 1982.
30. Chavkin C., James J., Goldstein A. Dynorphin is a specific endogenous ligand of kappa opioid receptor. Science 215: 413, 1982.
31. Atweh S.F., Kuhar M.J. Distribution and significance of opioid receptors in the brain. Br. Med. Bull. 39: 47, 1983.
32. Atweh S.F., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain spinal cord and lower medulla. Brain Res. 124: 53, 1977.
33. Atweh S.F., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain stem II. The brain stem. Brain Res. 129: 1, 1977.
34. Atweh S.F., Kuhar M.J. Autoradiographic localization of opiate receptors in rat brain III. The telencephalon. Brain Res. 134: 393, 1977.
35. Wuster M., Schultz R., Herz A. Multiple opiate receptors in peripheral tissue preparations. Biochem Pharmacol. 30: 1883, 1981.
36. Yoon D.J., Sklar C., David R. Presence of immunoreactive corticotropin-releasing factor in rat testis. Endocrinology 122: 759, 1988.
37. Audhya T., Hollander C.S., Schlesinger D.H., Hutchinson B. Structural characterization and localization of corticotropin-releasing factor in testis. Biochim. Biophys. Acta 995: 10, 1989.
38. Fabbri A., Tinajero J.C., Dufau M.L. Corticotropin-releasing factor is produced by rat Leydig cells and has a major local antireproductive role in the testis. Endocrinology 127: 1541, 1990.
39. Dufau M.L., Tinajero J.C., Fabbri A. Corticotropin-releasing factor: an antireproductive hormone of the testis. FASEB J 7: 299, 1993.
40. Huang B.M., Stocco D.M., Hutson J.C., Norman R.L. Corticotropin-releasing hormone stimulates steroidogenesis in mouse Leydig cells. Biol. Reprod. 53: 620, 1995.
41. Mastorakos G., Webster E., Friedman T., Chrousos G. Immunoreactive corticotropin-releasing hormone and its binding in the rat ovaries. J. Clin. Invest. 92: 961, 1993.
42. Mastorakos G., Scopa C., Vryonidou A., Friedman T., Kattis D., Phenekos C., Merino M., Chrousos G. Presence of immunoreactive corticotropin-releasing hormone in normal and polycystic human ovaries. J. Clin. Endocrinol. Metab. 79: 1191, 1994.
43. Grino M., Chrousos G., Margioris A. The corticotropin-releasing hormone gene is expressed in human placenta. Biochem. Biophys. Res. Commn. 148: 1208, 1987.
44. Margioris A.N. Corticotropin releasing hormone and the placenta and fetal membranes. In: Brennecke S., Rice G. (Eds.), Molecular aspects of placental and fetal membrane autacoids. CRC Press (publs) 1993, vol 12, p. 277.
45. Linton E.A., Perkins A.V., Woods R.J., Eben F., Wolfe C.D., Behan D.P., Potter E., Vale W.W., Lowry P.J. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. J. Clin. Endocrinol. Metab. 76: 260, 1993.
46. Campbell E.A., Linton E.A., Wolfe C.D., Scraggs P.R., Jones M.T., Lowry P.J. Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J. Clin. Endocrinol. Metab. 64: 1054, 1987.
47. Frim D., Emanuel R., Robinson B., Smas C., Adler G., Majzoub J. Characterization and gestational regulation of corticotropin-releasing hormone mRNA in human placenta. J. Clin. Invest. 82: 287, 1988.
48. Petraglia F., Sawchenko P.E., Rivier J., Vale W. Evidence for local stimulation of ACTH secretion by corticotropin-releasing factor in human placenta. Nature 328: 717, 1987.
49. Robinson B., Emanuel R., Frim D., Majzoub J. Glucocorticoid stimulates expression of corticotropin-releasing hormone gene in human placenta. Proc. Natl. Acad. Sci. 85: 5244, 1988.
50. Margioris A.N., Grino M., Protos P., Gold P., Chrousos G. Corticotropin-releasing hormone and oxytocin stimulate the release of placental proopiomelanocortin peptides. J. Clin. Endocrinol. Metab. 66: 922, 1988.
51. Petraglia F., Potter E., Cameron V.A., Sutton S., Behan D.P., Woods R.J., Sawchenko P.E., Lowry P.J., Vale W. Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J. Clin. Endocrinol. Metab. 77: 919, 1993.
52. Coukos G., Monzani A., Saletti C., Petraglia F. Noradrenaline and interleukin-1 stimulate CRF secretion from human placental cells in culture. Medicina 8: 441, 1988.
53. Margioris A.N., Grino M., Rabin D., Chrousos G.P. Human placenta and the hypothalamic-pituitary-adrenal axis. Adv. Exp. Med. Biol. 245: 389, 1988.
54. Hatzoglou A., Margioris A.N., Bakogeorgou E., Gravanis A., Castanas E. Identification, characterization and localization of corticotropin-releasing hormone receptors in human placenta. Life Sci. 59: 1871, 1996.
55. Quartero H.W., Fry C.H. Placental corticotrophin releasing factor may modulate human parturition. Placenta 10: 439, 1989.
56. Sasaki A., Tempst P., Liotta A.S., Margioris A.N., Hood L.E., Kent S.B., Sato S., Shinkawa O., Yoshinaga K., Krieger DT. Isolation and characterization of a corticotropin-releasing hormone-like peptide from human placenta. J. Clin. Endocrinol. Metab. 67: 768, 1988.
57. 5)enkephalin immunoreactivity in guinea pig and rat testis. Regul. Pept. 19: 17, 1987.
58. Pintar J.E., Schachter B.S., Herman A.B., Durgerian S., Krieger D.T. Characterization and localization of proopiomelanocortin messenger RNA in the adult rat testis. Science 225: 632, 1984.
59. Eskeland N.L., Molineaux C.J., Schacter B.S. Regulation of β-endorphin secretion by corticotropin-releasing factor in the intact rat testis. Endocrinology 130: 1173, 1992.
60. Fabri A., Tsai Morris C.H., Luna S., Fraioli F., Dufau M.L. Opiate receptors are present in rat testis. Identification and localization in Sertoli cells. Endocrinology 117: 2544, 1985.
61. Sharpe R.M., Cooper I. Comparison of the effects of the purified Leydig cells of four hormones (oxytocin, vasopressin, opiates and LHRH) with suggested paracrine roles in the testis. J. Endocrinol. 113: 89, 1987.
62. Margioris A.N., Sasaki A., Liotta A.S. Presence and preliminary characterization of immunoreactive dynorphin in human testis. (Abstract). Annual Meeting of The Endocrine Society, 1985: 511.
63. Mc Murray C.T., Devi L., Calavetta L., Douglass J.O. Regulated expression of prodynorphin gene in the R2C Leydig tumor cell line. Endocrinology 124: 49, 1988.
64. Chen C., Chang C., Krieger D.T., Bardin C.W. Expression and regulation of proopiomelanocortin-like gene in the ovary and placenta: comparison with the testis. Endocrinology 118: 2382, 1986.
65. Kilpatrick D.L., Howell R.D., Noe M., Bailey C.I., Udenfriend S. Expression of preproenkephalin-like mRNA and its peptide products in mammalian testis and ovary. Proc. Natl. Acad. Sci. 82: 7467, 1985.
66. Lim A.T., Lolait S., Barlow J.W., Wai Sum O., Zos I., Toh B.H., Funder J.W. Immunoreactive b-endorphine in sheep ovary. Nature 303: 709, 1983.
67. Lolait S.J., Autelitano D.J., Lim A.T.W., Smith A.I., Toh B.H., Funder J.W. Ovarian immunoreactive β-endorphin and estrus-cycle in the rat. Endocrinology 117: 161, 1985.
68. Facchineti F., Storchi A.R., Petraglia F., Volpe A., Genazzani A.R. Expression of proopiomelanocortin-related peptides in human follicular fluid. Peptides 9: 1089, 1988.
69. Sanders S.L., Meiner M.H., Curry Jr T.E. Cellular localization of ovarian proopiomelanocortin messenger RNA during follicular and luteal development in the rat. Mol. Endocrinol. 4: 1311, 1990.
70. Chen C.L.C. Expression and regulation of proopiomelanocortin gene and its physiological function in reproductive tissues. In: Martini L., Grong W.F. (Eds.), Frontiers in Neuroendocrinology, Gulyas B.J. Raven Press, Ltd., New York, 1988, vol. 99.
71. Genazzani A.R., Petraglia F., Di Meo G., Santoro V., Facchineti F., Sgre A. Prostaglandin-induced mid-pregnancy abortion increases plasma and amniotic fluid levels of β-lipotropin and β-endorphin. Gynecol. Obstet. Invest. 24: 23, 1987.
72. Lemaire S., Vallete A., Chounard L., Dupuis N., Day R., Porthe G., Gros J. Purification and identification of multiple forms of dynorphin in human placenta. Neuropeptides 3: 181, 1983.
73. Ahmed M.S., Randall L.W., Sibai B., Dass C., Fridland G., Desiderio D.M., Tolun E. Identification of dynorphin (1-8) in human placenta by mass spectrometry. Life Sci. 40: 2067, 1987.
74. Porthe G., Vallete A., Cros J. Kappa opiate binding sites in human placenta. Biochem. Biophys. Res. Com. 101: 1, 1981.
75. Valette A. Tafani M., Porthe G., Pontonnier G., Cros J. Placental Kappa binding sites: interaction with dynorphin and its possible implication in hCG secretion. Life Sci. 33: 523, 1983.
76. Ahmed M.S. Characterization of solubilized opiate receptors from human placenta. Membr. Biochem. 5: 35, 1983.
77. Belisle S., Petit A., Gallo-Payet N., Bellabarda D., Lehoux J.G., Lemaire S. Functional opioid receptor sites in human placentas. J. Clin. Endocrinol. Metab. 66: 283, 1988.
78. Makrigiannakis A., Zoumakis E., Margioris A.N., Theodoropoulos P., Stournaras C., Gravanis A. The corticotropin-releasing hormone in normal and tumoral epithelial cells of human endometrium. J. Clin. Endocrinol. Metab. 80: 185, 1995.
79. Mastorakos G., Scopa C.D., Kao L.C., Vryonidou A., Friedman T.C., Kattis D., Phenekos C., Rabin D., Chrousos G.P. Presence of immunoreactive corticotropin-releasing hormone in human endometrium. J. Clin. Endocrinol. Metab. 81: 1046, 1996.
80. Makrigiannakis A., Margioris A.N., LeGoascogne C., Zoumakis E., Nikas G., Stournaras C., Psychoyos A., Gravanis A. Corticotropin-releasing hormone (CRH) is expressed at the implantation sites of early pregnant rat uterus. Life Sci. 57: 1869, 1995.
81. Zoumakis E., Makrigiannakis A., Margioris A.N., Stournaras C., Gravanis A. Endometrial corticotropin releasing hormone (CRH): its potential autocrine - paracrine actions. Ann. N. Y. Acad. Sci. 1997 In press.
82. Zoumakis E., Makrigiannakis A., Margioris A.N., Stournaras C., Gravanis A. Corticotropin-releasing hormone (CRH) in normal and pregnant uterus: physiological implications. Frontiers in Bioscience 1: 1, 1996.
83. Petraglia F., Tabanelli S., Galassi C., Garuti G.C., Mancini A., Genazzani A., Gurpide E. Human decidua and in vitro decidualized endometrial stromal cells at term contain immunoreactive CRF and CRF mRNA. J. Clin. Endocrinol. Metab. 74: 1427, 1992.
84. Makrigiannakis A., Zoumakis E., Margioris A.N., Stournaras C., Chrousos G.P., Gravanis A. Regulation of the promoter of the human corticotropin-releasing hormone gene in transfected human endometrial cells. Neuroendocrinology 64: 85, 1996.
85. Makrigiannakis A., Psychoyos A., Zoumakis E., Margioris A.N., Stournaras C., Gravanis A. Endometrial corticotropin-releasing hormone (CRH): expression, regulation and potential physiological implications. Ann. N. Y. Acad. Sci. 1997. In press.
86. Makrigiannakis A., Margioris A.N., Stournaras C., Gravanis A. Opioid peptides in the female reproductive system. Physiological implications. Biomed. Rev. 4: 71, 1995.
87. Makrigiannakis A., Margioris A., Markogiannakis E., Stournaras C., Gravanis A. Steroid hormones regulate the release of immunoreactive β-endorphin from Ishikawa human endometrial cell line. J. Clin. Endocrinol. Metab. 75: 584, 1992.
88. Gravanis A., Makrigiannakis A., Stournaras C., Margioris A. Interactions between steroid hormones and endometrial opioid peptides. Ann. N.Y. Acad. Sci. 734: 245, 1994.
89. Hatzoglou A., Gravanis A., Margioris AN., Zoumakis E., Castanas E. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J. Clin. Endocrinol. Metab. 80: 418, 1995.
90. Karalis K., Sano H., Redwine J., Listwark S., Wilder R., Chrousos G. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science 254: 421, 1991.
91. Markiewitz L., Gravanis A., Schatz F., Holinka C., Gurpide E. Prostaglandin production by human endometrial adenocarcinoma. In: Baulieu E.E., Jacobeli S, McGuire W.L. (Eds.), Endocrinology and Malignancy Parthenon, New Jersey, 1986, p. 420.
92. Simon C., Frances A., Piquette G., Danasouri I., Zurawski G., Dang W., Polan M. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 134: 521, 1994.
93. Sheth K.V., Roca G.L., Al-Sedairy S., Parhar R., Hamilton G., Al-Abdul Jabbar F. Prediction of successful embryo implantation by measuring interleukin-1-alpha and immunosuppressive factor(s) in preimplantation. Fertil. Steril. 55: 952, 1991.
94. Ferrari A., Petraglia F., Gurpide E. Corticotropin releasing factor decidualizes human endometrial stromal cells in vitro. Interaction with progestin. J. Steroid. Biochem. Mol. Biol. 54: 251, 1995.
95. Grunt M., Glaser J., Schmidhuber H., Pauschinger P., Born J. Effects of corticotropin-releasing factor on isolated rat heart activity. Am. J. Physiol. 264: H1124, 1993.
96. Grammatopoulos D., Thompson S., Hillhouse E.W. The human myometrium expresses multiple isoforms of the corticotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab. 80: 2388, 1995.
97. Grammatopoulos D., Stirrat G.M., Williams S.A., Hillhouse E.W. The biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy. J. Clin. Endocrinol. Metab. 81: 745, 1996.
98. Grammatopoulos D., Milton N.G., Hillhouse E.W. The human myometrial CRH receptor: G proteins and second messengers. Mol. Cell. Endocrinol. 99: 245, 1994.